ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

437
Analysis
Health Care • South Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
bearish•Celltrion Healthcare
•24 Feb 2019 12:05

Celltrion Healthcare: Well, We Were Warned

Celltrion Healthcare (091990 KS) reported preliminary 2018 results that were dramatically short of expectations as the company cut shipments to...

Share
bullish•Samsung C&T
•15 Jan 2019 14:30

Samsung C&T: A Restructuring of Fashion Business Is Likely After the Stepping Down of Lee Seo-Hyun

Lee Seo-Hyun (age 46), the billionaire second daughter of the Samsung Group Lee Gun-Hee, recently stepped down from her position as the CEO...

Logo
798 Views
Share
bearish•Wuxi Biologics
•14 Jan 2019 04:16

WuXi Biologics – The Foxconn or Qualcomm of Global CDMO?

During the first week of 2019, we visited Wuxi Biologics (Cayman) Inc (2269 HK) headquarters in Shanghai, as well as spend time touring the lab....

Logo
951 Views
Share
•26 Dec 2018 07:42

Korean Stock Market Sectors 2018 Review & 2019 Outlook

In this report, we review the major sectors' performance in the Korean stock market in 2018 and also provide our outlook for them in 2019. We...

Logo
1.1k Views
Share
bearish•Celltrion Inc
•13 Dec 2018 10:06

Celltrion / Celltrion Healthcare Pair Trade: Ratio Should Move in Favor of Healthcare

I initiated a pair trade (short Celltrion / long Healthcare) on Oct 22. Yield peaked at 16.66% on Nov 22. It now stays at 8.75%. The ongoing FSS...

Logo
697 Views
Share
x